Penicillin skin testing in cardiac surgery

David J. Cook, David W. Barbara, Karen E. Singh, Joseph A. Dearani

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background Penicillin is the most commonly reported allergy in cardiac surgical patients and a history of penicillin allergy frequently results in the use of vancomycin for antibiotic prophylaxis. However, clinical history is unreliable and true allergy is rare. Penicillin allergy testing has the potential to reduce vancomycin use and indirectly the potential for selection of vancomycin-resistant organisms, a national priority. Methods After the publication of the 2007 Society of Thoracic Surgeons practice guideline report, we initiated a penicillin allergy testing service for cardiac surgical patients in 2009. We sought to determine the true incidence of penicillin allergy in the tested population, whether testing availability reduced vancomycin use in those tested, and if vancomycin use was reduced in the entire cardiac surgical population as a whole. Results A total of 276 patients were skin tested for allergy to penicillin or cephalosporin. Testing recommended no penicillin use in 13.8% of those tested giving a true penicillin allergy incidence of 0.9%. Only 24 of the 276 patients tested (9%) received vancomycin. However, given the small percentage of the total population that underwent allergy testing, the overall use of vancomycin in the cardiac surgery practice was not reduced in the posttesting period. Conclusions The true rate of contraindication to penicillin in a cardiac surgical population is very low. Penicillin allergy testing can reduce vancomycin use in the tested population, but better means of conducting the testing and making the results available are necessary to reduce unnecessary vancomycin use in a broader cardiac surgical population.

Original languageEnglish (US)
Pages (from-to)1931-1935
Number of pages5
JournalJournal of Thoracic and Cardiovascular Surgery
Volume147
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Penicillins
Vancomycin
Thoracic Surgery
Hypersensitivity
Skin
Population
Antibiotic Prophylaxis
Incidence
Cephalosporins
Practice Guidelines
Publications

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Cook, D. J., Barbara, D. W., Singh, K. E., & Dearani, J. A. (2014). Penicillin skin testing in cardiac surgery. Journal of Thoracic and Cardiovascular Surgery, 147(6), 1931-1935. https://doi.org/10.1016/j.jtcvs.2014.01.019

Penicillin skin testing in cardiac surgery. / Cook, David J.; Barbara, David W.; Singh, Karen E.; Dearani, Joseph A.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 147, No. 6, 2014, p. 1931-1935.

Research output: Contribution to journalArticle

Cook, DJ, Barbara, DW, Singh, KE & Dearani, JA 2014, 'Penicillin skin testing in cardiac surgery', Journal of Thoracic and Cardiovascular Surgery, vol. 147, no. 6, pp. 1931-1935. https://doi.org/10.1016/j.jtcvs.2014.01.019
Cook, David J. ; Barbara, David W. ; Singh, Karen E. ; Dearani, Joseph A. / Penicillin skin testing in cardiac surgery. In: Journal of Thoracic and Cardiovascular Surgery. 2014 ; Vol. 147, No. 6. pp. 1931-1935.
@article{05054e17552d40f2ad3a3dd15538e190,
title = "Penicillin skin testing in cardiac surgery",
abstract = "Background Penicillin is the most commonly reported allergy in cardiac surgical patients and a history of penicillin allergy frequently results in the use of vancomycin for antibiotic prophylaxis. However, clinical history is unreliable and true allergy is rare. Penicillin allergy testing has the potential to reduce vancomycin use and indirectly the potential for selection of vancomycin-resistant organisms, a national priority. Methods After the publication of the 2007 Society of Thoracic Surgeons practice guideline report, we initiated a penicillin allergy testing service for cardiac surgical patients in 2009. We sought to determine the true incidence of penicillin allergy in the tested population, whether testing availability reduced vancomycin use in those tested, and if vancomycin use was reduced in the entire cardiac surgical population as a whole. Results A total of 276 patients were skin tested for allergy to penicillin or cephalosporin. Testing recommended no penicillin use in 13.8{\%} of those tested giving a true penicillin allergy incidence of 0.9{\%}. Only 24 of the 276 patients tested (9{\%}) received vancomycin. However, given the small percentage of the total population that underwent allergy testing, the overall use of vancomycin in the cardiac surgery practice was not reduced in the posttesting period. Conclusions The true rate of contraindication to penicillin in a cardiac surgical population is very low. Penicillin allergy testing can reduce vancomycin use in the tested population, but better means of conducting the testing and making the results available are necessary to reduce unnecessary vancomycin use in a broader cardiac surgical population.",
author = "Cook, {David J.} and Barbara, {David W.} and Singh, {Karen E.} and Dearani, {Joseph A.}",
year = "2014",
doi = "10.1016/j.jtcvs.2014.01.019",
language = "English (US)",
volume = "147",
pages = "1931--1935",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Penicillin skin testing in cardiac surgery

AU - Cook, David J.

AU - Barbara, David W.

AU - Singh, Karen E.

AU - Dearani, Joseph A.

PY - 2014

Y1 - 2014

N2 - Background Penicillin is the most commonly reported allergy in cardiac surgical patients and a history of penicillin allergy frequently results in the use of vancomycin for antibiotic prophylaxis. However, clinical history is unreliable and true allergy is rare. Penicillin allergy testing has the potential to reduce vancomycin use and indirectly the potential for selection of vancomycin-resistant organisms, a national priority. Methods After the publication of the 2007 Society of Thoracic Surgeons practice guideline report, we initiated a penicillin allergy testing service for cardiac surgical patients in 2009. We sought to determine the true incidence of penicillin allergy in the tested population, whether testing availability reduced vancomycin use in those tested, and if vancomycin use was reduced in the entire cardiac surgical population as a whole. Results A total of 276 patients were skin tested for allergy to penicillin or cephalosporin. Testing recommended no penicillin use in 13.8% of those tested giving a true penicillin allergy incidence of 0.9%. Only 24 of the 276 patients tested (9%) received vancomycin. However, given the small percentage of the total population that underwent allergy testing, the overall use of vancomycin in the cardiac surgery practice was not reduced in the posttesting period. Conclusions The true rate of contraindication to penicillin in a cardiac surgical population is very low. Penicillin allergy testing can reduce vancomycin use in the tested population, but better means of conducting the testing and making the results available are necessary to reduce unnecessary vancomycin use in a broader cardiac surgical population.

AB - Background Penicillin is the most commonly reported allergy in cardiac surgical patients and a history of penicillin allergy frequently results in the use of vancomycin for antibiotic prophylaxis. However, clinical history is unreliable and true allergy is rare. Penicillin allergy testing has the potential to reduce vancomycin use and indirectly the potential for selection of vancomycin-resistant organisms, a national priority. Methods After the publication of the 2007 Society of Thoracic Surgeons practice guideline report, we initiated a penicillin allergy testing service for cardiac surgical patients in 2009. We sought to determine the true incidence of penicillin allergy in the tested population, whether testing availability reduced vancomycin use in those tested, and if vancomycin use was reduced in the entire cardiac surgical population as a whole. Results A total of 276 patients were skin tested for allergy to penicillin or cephalosporin. Testing recommended no penicillin use in 13.8% of those tested giving a true penicillin allergy incidence of 0.9%. Only 24 of the 276 patients tested (9%) received vancomycin. However, given the small percentage of the total population that underwent allergy testing, the overall use of vancomycin in the cardiac surgery practice was not reduced in the posttesting period. Conclusions The true rate of contraindication to penicillin in a cardiac surgical population is very low. Penicillin allergy testing can reduce vancomycin use in the tested population, but better means of conducting the testing and making the results available are necessary to reduce unnecessary vancomycin use in a broader cardiac surgical population.

UR - http://www.scopus.com/inward/record.url?scp=84901202886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901202886&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2014.01.019

DO - 10.1016/j.jtcvs.2014.01.019

M3 - Article

C2 - 24530197

AN - SCOPUS:84901202886

VL - 147

SP - 1931

EP - 1935

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 6

ER -